Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

RFL9 encodes an A2b-adenosine receptor.

S A Rivkees¹, S M Reppert

¹Laboratory of Developmental Chronobiology, Massachusetts General Hospital, Boston.

Molecular Endocrinology (Baltimore, Md.)

|October 1, 1992

Summary

Researchers identified a novel adenosine receptor subtype, RFL9, which encodes the A2b-adenosine receptor. This discovery facilitates further study of A2b-adenosine receptor distribution and function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

EDITORIAL. Why the Consensus for Consensus?

Journal of pediatric endocrinology & metabolism : JPEM·2021

Same author

Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium.

Cancer treatment reviews·2017

Same author

Controversies in the management of Graves' disease in children.

Journal of endocrinological investigation·2016

Same author

Identification and localization of secretin and secretin receptor mRNAs in rat testis.

Endocrine·2010

Same author

The human A1 adenosine receptor: ligand binding properties, sites of somatic expression and chromosomal localization.

Endocrine·2010

Same author

Prevalence and risk factors for disrupted circadian rhythmicity in children with optic nerve hypoplasia.

The British journal of ophthalmology·2010

Area of Science:

Pharmacology
Molecular Biology
Receptor Biology

Background:

Adenosine receptors play crucial roles in various physiological processes.
A novel adenosine receptor subtype, RFL9, was previously cloned.
Characterization of adenosine receptor subtypes is essential for understanding cellular signaling.

Purpose of the Study:

To pharmacologically characterize the novel RFL9 adenosine receptor.
To determine if RFL9 represents the A2b-adenosine receptor subtype.
To investigate the expression of RFL9 in human fibroblasts.

Main Methods:

Stable transfection of Chinese Hamster Ovary (CHO) cells with RFL9 cDNA.
Measurement of cyclic adenosine monophosphate (cAMP) responses to drug treatments.
Northern blot analysis and polymerase chain reaction (PCR) for gene expression analysis.

Main Results:

RFL9-transfected cells exhibited cAMP responses consistent with A2b-adenosine receptors, distinct from A2a-adenosine receptors.
Pharmacological profiles of RFL9-transfected cells strongly correlated with endogenous A2b-adenosine receptors in VA 13 fibroblasts.
Northern blot and PCR analyses confirmed RFL9 expression in VA 13 fibroblasts and the absence of A2a-adenosine receptor mRNA.

Conclusions:

The cDNA designated RFL9 encodes the A2b-adenosine receptor subtype.
This identification enables detailed investigation into the anatomical distribution and functional roles of A2b-adenosine receptors.
The findings contribute to a deeper understanding of adenosine receptor signaling pathways.

Related Experiment Videos